110 likes | 129 Views
According to the latest research report by IMARC Group, The global continuous glucose monitoring systems market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2023-2028.<br><br>More Info:- https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market
E N D
Global Continuous Glucose Monitoring Systems Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Continuous Glucose Monitoring Systems Market Research Report: The latest report by IMARC, titled “Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " the global continuous glucose monitoring systems market size reached US$ 6.1 Billion in 2022. Continuous glucose monitoring systems (CGMS) are medical devices that track blood glucose levels throughout the day using small sensors inserted under the skin. They consist of sensors, transmitters, and receivers to collect, measure, and display glucose level data. CGMS aid in monitoring glucose trends over time by providing valuable information at crucial points, such as before and during exercise and in the middle of the night. These devices also offer a complete diabetes profile, detect patterns, and evaluate and measure the effects of diet, medications, and physical activity on sugar levels, thus reducing the chances of hypo/hyperglycemia. As compared to conventional glucose monitoring machines, CGMS are painless and minimize the number of finger-prick tests, as it uses interstitial fluid to measure glucose levels instead of blood. Request Free Sample Report: https://www.imarcgroup.com/continuous-glucose-monitoring- systems-market/requestsample
Report Description and Highlights Report Description Global Continuous Glucose Monitoring Systems Market Trends: The rising prevalence of diabetes due to sedentary lifestyles and obesity is one of the primary factors driving the market growth. CGMS is widely used to track glucose levels in real-time, which aids in determining the effectiveness of treatment plans and allows patients to make more informed decisions regarding physical activity, a balanced diet, and medications. Furthermore, rising product adoption among patients using intensive insulin therapy to improve glycemic control, reduce the occurrence of hypoglycemia events, and assist in tailoring the insulin doses to improve hemoglobin A1c (HbA1c) levels is creating a positive outlook for the market. Additionally, the integration of artificial intelligence (AI) to develop a decision support system that provides advanced diabetes management through personalized insulin bolus calculation, adaptive tuning of bolus calculator parameters, and glucose prediction is providing an impetus to the market growth. Moreover, the implementation of various government initiatives to manage diabetes at a larger scale and spread awareness regarding preventive care measure is facilitating the market growth. Other factors, including rising health consciousness among consumers, extensive research and development (R&D) activities, and easy product availability across various e-commerce platforms, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 8.6 Billion by 2028, exhibiting a CAGR of 5.7% during 2023-2028. Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Report Description and Highlights Report Description Market Summary: Breakup by Component: • Sensors • Transmitters and Receivers • Integrated Insulin Pumps Breakup by Demographics: • Child Population (≤14 years) • Adult Population (>14 years) Breakup by End User: • Clinics and Diagnostics Centers • ICUs • Home Healthcare Breakup by Region: • North America • United States • Canada
Report Description and Highlights Report Description • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa
Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • • A. Menarini Diagnostics S.r.l. Abbott Laboratories DexCom Inc. F. Hoffmann-La Roche AG Glysens Incorporated LifeScan Inc. (Johnson & Johnson) Medtronic PLC Medtrum Technologies Inc. Nemaura Medical Inc. Novo Nordisk A/S Senseonics Holdings Inc. Waveform Technologies Inc. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/continuous-glucose- monitoring-systems-market
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com